NCT06738108View on ClinicalTrials.gov

EKOS in Patients With Pulmonary Embolism (PE)

CompletedOBSERVATIONAL

Enrollment

104

Participants

Timeline

Start Date

December 13, 2024

Primary Completion Date

December 20, 2024

Study Completion Date

January 8, 2025

Conditions

Pulmonary Embolism

Interventions

DRUG

ECOS

The EkoSonic Endovascular System, developed by EKOS Corporation, is a specialized CDT system that combines ultrasound technology with thrombolytic infusion to treat PE

DRUG

Control group

Alteplase IV infusion

Trial Locations (1)

Unknown

Saudi German Hospital, Cairo

All Listed Sponsors

lead

Beni-Suef University

OTHER

NCT06738108 - EKOS in Patients With Pulmonary Embolism (PE) | Biotech Hunter | Biotech Hunter